Focus: Perimeter Medical Imaging AI develops AI-powered surgical imaging technology focused on real-time cancer margin identification during oncology procedures. The company operates as a specialized medical device/AI biotech focused on intraoperative guidance.
Profile data last refreshed 20h ago · AI intelligence enriched 3w ago
Stable — net +1 jobs in 30d
4 added, 3 removed. Backfill posture.
A high-risk, high-upside opportunity for career builders comfortable with early-stage biotech uncertainty but attracted to a narrowly focused, clinically differentiated technology in oncology.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Perimeter Medical Imaging AI
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Perimeter Medical Imaging AI's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo